What do you quote as the recurrence risk without radiation for patients that undergo neoadjuvant systemic therapy followed by lumpectomy and are found to have a complete pathologic response?

Patients will frequently ask why they need treatment when there is no cancer left on the pathology specimen.

Answer from: Radiation Oncologist at Community Practice

We don’t have any data to quote and this is still an unanswered question. Rather, there is an interesting phase 2 study omitting surgery in these, it’s showing excellent outcomes.Kuerer et al., PMID 36306810

Comments

Radiation Oncologist at West Virginia University
Perhaps a response referencing the Taiwanese study...

Please select the option that best describes you:

What do you quote as the recurrence risk without radiation for patients that undergo neoadjuvant systemic therapy followed by lumpectomy and are found to have a complete pathologic response?

Related Questions